News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,414 Results
Type
Article (334)
Press Release (10080)
Section
Business (2609)
Deals (450)
Drug Delivery (1)
Drug Development (2491)
FDA (399)
Job Trends (372)
News (5851)
Policy (463)
Tag
Academia (27)
Allergies (4)
Alliances (555)
Alzheimer's disease (8)
Antibody-drug conjugate (ADC) (2)
Approvals (408)
Autoimmune disease (2)
Bankruptcy (3)
Best Places to Work (383)
Biosimilars (2)
Bladder cancer (9)
Breast cancer (3)
Cancer (56)
Cardiovascular disease (2)
Cell therapy (9)
Cervical cancer (3)
Clinical research (2235)
Collaboration (19)
Compensation (11)
COVID-19 (9)
CRISPR (1)
C-suite (7)
Cystic fibrosis (1)
Data (122)
Diabetes (11)
Diagnostics (33)
Drug pricing (1)
Duchenne muscular dystrophy (2)
Earnings (1204)
Events (1683)
Executive appointments (13)
FDA (453)
Funding (10)
Gene editing (2)
Gene therapy (22)
GLP-1 (8)
Government (54)
Grass and pollen (1)
Guidances (2)
Healthcare (269)
Immunology and inflammation (3)
Infectious disease (10)
Influenza (1)
Intellectual property (2)
IPO (259)
Job creations (20)
Layoffs (7)
Legal (34)
Liver cancer (4)
Lung cancer (17)
Manufacturing (1)
Medical device (175)
Medtech (175)
Mergers & acquisitions (209)
Metabolic disorders (12)
Multiple sclerosis (2)
Neuroscience (11)
NextGen: Class of 2025 (55)
Non-profit (16)
Now hiring (1)
Ovarian cancer (6)
Pain (12)
Patents (4)
Patient recruitment (6)
People (828)
Phase I (510)
Phase II (987)
Phase III (934)
Pipeline (48)
Policy (1)
Postmarket research (60)
Preclinical (188)
Prostate cancer (1)
Radiopharmaceuticals (4)
Rare diseases (4)
Real estate (22)
Regulatory (449)
Reports (1)
Research institute (20)
Series A (1)
Series B (2)
Sickle cell disease (1)
Startups (60)
The Weekly (1)
Vaccines (5)
Weight loss (1)
Date
Today (4)
Last 7 days (23)
Last 30 days (86)
Last 365 days (774)
2025 (298)
2024 (853)
2023 (974)
2022 (1129)
2021 (1264)
2020 (941)
2019 (686)
2018 (516)
2017 (557)
2016 (497)
2015 (586)
2014 (379)
2013 (223)
2012 (204)
2011 (221)
2010 (238)
Location
Africa (2)
Arizona (1)
Asia (496)
Australia (75)
California (124)
Canada (15)
China (8)
Connecticut (2)
Delaware (11)
Europe (1382)
Florida (7)
Georgia (19)
Idaho (5)
Illinois (11)
India (2)
Indiana (2)
Japan (6)
Kentucky (1)
Maryland (14)
Massachusetts (146)
Michigan (6)
Minnesota (2)
New Jersey (59)
New York (45)
North Carolina (31)
Northern California (58)
Ohio (3)
Pennsylvania (33)
Rhode Island (1)
South America (6)
Southern California (47)
Tennessee (6)
Texas (12)
United States (542)
Virginia (1)
Washington State (12)
10,414 Results for "ocular therapeutix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ocular Therapeutix™ to Participate in Upcoming Investor Conferences
May 14, 2025
·
2 min read
Press Releases
Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
April 30, 2025
·
4 min read
Press Releases
Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights
May 5, 2025
·
18 min read
Press Releases
Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
April 29, 2025
·
1 min read
Press Releases
Ocular Therapeutix™ to Participate in Two Investor Conferences in April 2025
April 1, 2025
·
1 min read
Press Releases
Ocular Therapeutix™ to Present at Two Investor Conferences in March 2025
February 26, 2025
·
1 min read
Press Releases
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 11, 2025
April 13, 2025
·
2 min read
Press Releases
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights
March 4, 2025
·
22 min read
Press Releases
Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025
February 24, 2025
·
1 min read
Press Releases
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 7, 2025
March 10, 2025
·
2 min read
1 of 1,042
Next
